Top Suppliers:I want be here
Related CAS#:
183322-45-4 153436-54-5
1700663-41-7 2711717-77-8
16154-78-2 82640-04-8
864374-00-5 15687-41-9
869884-77-5 6108-05-0
1158522-08-7 940364-43-2
134104-43-1 131615-57-1
6906-52-1 930439-75-1
1018584-77-4 1375289-11-4
849349-65-1 1260877-95-9

183322-45-4

183322-45-4 structure
183322-45-4 structure
  • Name: PD153035 HCl
  • Chemical Name: N-(3-bromophenyl)-6,7-dimethoxyquinazolin-4-amine,hydrochloride
  • CAS Number: 183322-45-4
  • Molecular Formula: C16H15BrClN3O2
  • Molecular Weight: 396.666
  • Catalog: Biochemical Inhibitor Protein tyrosine kinase
  • Create Date: 2018-12-25 11:14:50
  • Modify Date: 2024-01-02 18:45:31
  • PD153035 (ZM 252868;AG 1517;Tyrphostin AG 1517;SU 5271) is a potent EGFR inhibitor with Ki and IC50 of 6 and 25 pM, respectively.
Name N-(3-bromophenyl)-6,7-dimethoxyquinazolin-4-amine,hydrochloride
Synonyms Tyrphostin AG 1517
N-(3-Bromophenyl)-6,7-dimethoxy-4-quinazolinamine hydrochloride (1:1)
N-(3-Bromophenyl)-6,7-dimethoxyquinazolin-4-amine hydrochloride
PD-153035 HYDROCHLORIDE
4-[(3-BROMOPHENYL)AMINO]-6,7-DIMETHOXYQUINAZOLINE HYDROCHLORIDE
4-Quinazolinamine, N-(3-bromophenyl)-6,7-dimethoxy-, hydrochloride (1:1)
N-(3-Bromophenyl)-6,7-dimethoxyquinazolin-4-amine hydrochloride (1:1)
PD153035 HCl
PD153035 HCL
SU-5271
AG1517
PD153035 Hydrochloride
Description PD153035 (ZM 252868;AG 1517;Tyrphostin AG 1517;SU 5271) is a potent EGFR inhibitor with Ki and IC50 of 6 and 25 pM, respectively.
Related Catalog
Target

EGFR:6 pM (Ki)

EGFR:25 pM (IC50)

In Vitro PD153035 inhibits EGF-stimulated receptor autophosphorylation in A431 human epidermoid carcinoma cells, with an IC50 of 14 nM[1]. PD 153035 has little effect on PDGFR, FGFR, CSF-1 receptor, the insulin receptor, or on src tyrosine kinases at concentrations as high as 50 μM. PD 153035 rapidly suppresses autophosphorylation of the EGF receptor at low nanomolar concentrations in fibroblasts or in human epidermoid carcinoma cells and selectively blocks EGF-mediated cellular processes including mitogenesis, early gene expression, and oncogenic transformation[2]. PD153035 causes a dose-dependent growth inhibition of EGF receptor-positive cell lines, beginning at less than micromolar concentrations, and the IC50 is less than 1 pM in most cases[3].
In Vivo PD153035 levels in the plasma and tumor rise to 50 and 22 μM within 15 minutes following a single i.p. dose of 80 mg/kg. While the plasma levels of PD 153035 falls below 1 μM by 3 hours, in the tumors it remains at micromolar concentrations for at least 12 hours. The tyrosine phosphorylation of the EGF receptor is rapidly suppressed by 80-90% in the tumors[4].
Cell Assay Different EGF receptor-overexpressing cell lines (A43 1, Difi, MDA-MB-468, MDA-MB-231, DU145, SiHa, C4i, and MEl 80) are treated with PD153035 at increasing concentrations of 0.125-2.5 p.M. Growth inhibitory effect in monolayer cell culture is assessed[3].
Animal Admin Mice: Mice are injected with PD153035 (80 mg/kg) or vehicle and rumors are excised at 20 minutes and 180 minutes and extracts are prepared. Two mice are used for each time point and the experiment is repeated four times. Within each of the four experiments ANOVA is used to compare the inhibition by PD 153035 of the EGF-stimulation[3].
References

[1]. Bridges AJ, et al. Tyrosine kinase inhibitors. 8. An unusually steep structure-activity relationship for analogues of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptor. J Med Chem. 1996 Jan 5;39(1):267-76.

[2]. Fry DW, et al. A specific inhibitor of the epidermal growth factor receptor tyrosine kinase. Science. 1994 Aug 19;265(5175):1093-5.

[3]. Bos M, et al. PD153035, a tyrosine kinase inhibitor, prevents epidermal growth factor receptoractivation and inhibits growth of cancer cells in a receptor number-dependent manner. Clin Cancer Res. 1997 Nov;3(11):2099-106.

[4]. Kunkel MW, et al. Inhibition of the epidermal growth factor receptor tyrosine kinase by PD153035 in human A431 tumors in athymic nude mice. Invest New Drugs. 1996;13(4):295-302.
Boiling Point 472.1ºC at 760 mmHg
Melting Point 265°C(lit.)
Molecular Formula C16H15BrClN3O2
Molecular Weight 396.666
Flash Point 239.3ºC
Exact Mass 395.003601
PSA 56.27000
LogP 5.02810
Appearance white to beige
Storage condition 2-8°C
Water Solubility DMSO: soluble2mg/mL, clear (warmed)
Symbol GHS05 GHS06
GHS05, GHS06
Signal Word Danger
Hazard Statements H301-H315-H318-H335
Precautionary Statements P261-P280-P301 + P310-P305 + P351 + P338
Hazard Codes T
Risk Phrases 25-37/38-41
Safety Phrases 26-39-45
RIDADR UN 2811 6.1 / PGIII
HS Code 2933990090
HS Code 2933990090
Summary 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Chemsrc provides CAS#:183322-45-4 MSDS, density, melting point, boiling point, structure, formula, molecular weight, synthetic route, etc.
title: CAS No. 183322-45-4 | Chemsrc address: https://www.chemsrc.com/en/baike/406806.html

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2024 ChemSrc All Rights Reserved